Skip to main content
. 2024 Aug 13;44(10):2057–2066. doi: 10.1007/s00296-024-05671-9

Table 2.

Risk table

Mode of action Month At risk (n) At risk (%) Cumulative events (n) Cumulative censored (n) Strata size (n) Drug survival
propability
IL-17i 0 190 100 5 0 190 100.0%
IL-17i 12 122 64 48 21 190 75.3%
IL-17i 24 99 52 53 39 190 72.6%
JAKi 0 78 100 8 0 78 100.0%
JAKi 12 46 59 27 5 78 65.4%
JAKi 24 26 33 29 23 78 62.8%
TNFi 0 954 100 19 0 954 100.0%
TNFi 12 702 74 155 103 954 84.4%
TNFi 24 559 59 198 200 954 79.6%